|
Rolf Henel is the retired President of Cyanamid International Lederle Division. He currently serves as an advisor to the healthcare industry and is a partner in Naimark & Associates a healthcare consulting firm. He is also a director and member of the Audit and Nominating and Corporate Governance Committees of SciClone Pharmaceuticals Inc. and a director Chair of the Compensation Committee and member of the Audit Committee of Penwest Pharmaceuticals Co. | 